Extensive
efforts have been devoted to developing desulfurization catalysts
to effectively remove sulfur from fuel. Active phase metals including
cobalt, nickel, molybdenum, and tungsten have been extensively used
in industry for hydrotreating/hydrodesulfurization catalysts for over
50 years. However, while it is desirable to use inexpensive materials
to do the same job, it is a grand challenge. Herein, we report a Fe-based
sulfide catalyst that is tuned by zinc with high activity for HDS,
which shows an industrial application potential to replace industrial
Mo-based catalysts. With an optimal configuration that has a Fe:Zn
ratio close to 1:1, the reaction rate constants of the dibenzothiophene
(DBT) and 4,6-dimethydibenzothiophene (4,6-DMDBT) HDS are increased
by 9.2 and 17.4 times, respectively, in comparison with the sums of
those on the monoiron and zinc sulfides. HDS activity for the sterically
hindered 4,6-DMDBT on the FeZn sulfide catalyst is even close to that
of Co-MoS2. The experimental results indicate that the
addition of Zn greatly modifies the electronic properties of iron
sulfide by transferring electrons from Zn to Fe, which tunes the d
band center to modulate the adsorption behavior of DBT and 4,6-DMDBT.
In combination with theoretical calculations, our experiments show
that the addition of Zn dramatically tunes the formation of sulfur
vacancies. We propose that the formation of sulfur vacancies is the
critical factor for designing highly efficient Fe-based sulfide catalysts.
This study provides the design principle of low-cost desulfurization
catalysts for industrial refinery applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.